Advanced Oncotherapy PLC Stock London S.E.
Equities
GB00B16JQ761
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-09 | Advanced Oncotherapy Delists from London Bourse Amid Financing Deal | MT |
05-03 | Advanced Oncotherapy financing talks continue, funds delayed | AN |
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M 234M |
---|---|---|---|---|---|
Net income 2020 | -25M -34.06M | Net income 2021 | -29M -39.51M | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M 65.83M | Net Debt 2021 | 49.09M 66.89M | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 14-08-26 | |
Director of Finance/CFO | - | 16-09-30 | |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Cross
BRD | Director/Board Member | 64 | 20-09-28 |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Hans von Celsing
BRD | Director/Board Member | 74 | 17-01-25 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 227B | |
+15.46% | 197B | |
+18.58% | 141B | |
+30.36% | 110B | |
+0.65% | 64.15B | |
+17.74% | 53.72B | |
+5.82% | 51.75B | |
+11.23% | 45.2B | |
+5.73% | 37.37B |